Harnessing Artificial Intelligence to Overcome Key Challenges in Psychedelic Research and Therapy.
ACS medicinal chemistry letters January 9, 2025 DOI: 10.1021/acsmedchemlett.4c00548 via PubMed
Summary
AI-generated from the abstractArtificial intelligence can enhance psychedelic research by helping to personalize treatment, predict therapeutic outcomes, and untangle the complex biological and environmental factors involved. AI models offer new understanding of long-term efficacy, how to optimize set and setting, and alternative treatment approaches, moving psychedelic therapy toward personalized medicine.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Key finding | AI-driven models provide new insights into long-term efficacy, set and setting optimization, and alternative treatment methods, advancing psychedelic therapy into personalized medicine. |
Abstract
Artificial intelligence (AI) offers transformative potential in psychedelic research by addressing limitations in personalized treatment, predicting therapeutic outcomes, and understanding complex biological and environmental factors. AI-driven models provide new insights into long-term efficacy, set and setting optimization, and alternative treatment methods, advancing psychedelic therapy into personalized medicine.